{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T13:06:54Z","timestamp":1648645614553},"reference-count":7,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.endinu.2018.09.004","type":"journal-article","created":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T13:53:30Z","timestamp":1543067610000},"page":"204-206","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor neuroendocrino pancre\u00e1tico secretor de corticotropina, un reto en el manejo terap\u00e9utico. A prop\u00f3sito de 2 casos"],"prefix":"10.1016","volume":"66","author":[{"given":"Andreu","family":"Sim\u00f3-Servat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inma","family":"Peir\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carles","family":"Villabona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endinu.2018.09.004_bib0040","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/PAS.0000000000000340","article-title":"ACTH-secreting pancreatic neoplasms associated with Cushing syndrome: Clinicopathologic study of 11 cases and review of the literature","volume":"39","author":"Maragliano","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.endinu.2018.09.004_bib0045","first-page":"451","article-title":"Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: A multicenter study","volume":"176","author":"Vittoria","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2018.09.004_bib0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.endinu.2018.02.001","article-title":"S\u00edndrome de Cushing ect\u00f3pico: descripci\u00f3n de 9 casos","volume":"65","author":"Araujo","year":"2018","journal-title":"Endocrinol Diabetes Nutr."},{"key":"10.1016\/j.endinu.2018.09.004_bib0055","first-page":"773","article-title":"Functional pancreatic neuroendocrine tumour causing Cushing's syndrome: The effect of chemotherapy on clinical symptoms","volume":"11","author":"Henrique do Amor Divino","year":"2017","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.endinu.2018.09.004_bib0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1472-6823-14-70","article-title":"Evolution in functionality of a metastatic pancreatic neuroendocrine tumour (pNET) causing Cushing's syndrome: Treatment response with chemotherapy","volume":"14","author":"Panicker","year":"2014","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.endinu.2018.09.004_bib0065","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors","volume":"364","author":"Yao","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.endinu.2018.09.004_bib0070","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMoa1003825","article-title":"Sunitinib malate for the treatment of pancreatic neuroendocrine tumors","volume":"364","author":"Raymond","year":"2011","journal-title":"N Engl J Med."}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016418302386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016418302386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T13:22:11Z","timestamp":1552310531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530016418302386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S2530016418302386"],"URL":"https:\/\/doi.org\/10.1016\/j.endinu.2018.09.004","relation":{},"ISSN":["2530-0164"],"issn-type":[{"value":"2530-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor neuroendocrino pancre\u00e1tico secretor de corticotropina, un reto en el manejo terap\u00e9utico. A prop\u00f3sito de 2 casos","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2018.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 SEEN y SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}